SCHEMBL6837529

SCHEMBL6837529

COc1ccc(CNC2CCC2)c2cc(C(=O)Nc3ccccc3)oc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.48
PDE4B Q07343 3/20 0.48
PDE4C Q08493 3/20 0.48
PDE4D Q08499 3/20 0.48
HTT P42858 3/20 0.45
ADRA2A P08913 3/20 0.44
ADRA2B P18089 3/20 0.44
ADRA2C P18825 3/20 0.44
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
ACHE P22303 3/20 0.42
BCHE P06276 2/20 0.42
ALOX5 P09917 1/20 0.41
BACE1 P56817 1/20 0.41
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837598 0.98 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6837518 0.97 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6836480 0.97 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6836658 0.91 TP53 (0.46) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6836474 0.91 ADRA2A (0.43) PDE4APDE4BPDE4CPDE4DADRA2A
SCHEMBL6836842 0.90 KMT2A (0.52) PDE4APDE4BPDE4CPDE4DADRA2A
SCHEMBL6837771 0.89 MAPT (0.44) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6837739 0.89 MEN1 (0.46) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6837873 0.89 HTT (0.48) PDE4APDE4BPDE4CPDE4DHTT
SCHEMBL6837867 0.88 ADRA2A (0.43) PDE4APDE4BPDE4CPDE4DHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 PDE4A 4879/4885PDE4B 4877/4885PDE4C 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.